BeOne Medicines is significantly bolstering its presence in the United States with a substantial $300 million investment earmarked for the…
Read More
FUJIFILM Biotechnologies COO Maja Herold Pedersen on AI, autonomy and the path from quality to operations
FUJIFILM Biotechnologies, a prominent contract development and manufacturing organization (CDMO), is currently navigating a period of unprecedented expansion, marked by…
Read More
FUJIFILM Biotechnologies COO Maja Herold Pedersen on AI, autonomy and the path from quality to operations
FUJIFILM Biotechnologies, a prominent contract development and manufacturing organization (CDMO), is currently executing a monumental expansion strategy, with approximately $7…
Read More
FUJIFILM Biotechnologies COO Maja Herold Pedersen on AI, autonomy and the path from quality to operations
FUJIFILM Biotechnologies, a prominent contract development and manufacturing organization (CDMO), is currently navigating an unprecedented phase of strategic expansion, marked…
Read More
FUJIFILM Biotechnologies COO Maja Herold Pedersen on AI, autonomy and the path from quality to operations
FUJIFILM Biotechnologies, a prominent contract development and manufacturing organization (CDMO), is currently experiencing an unprecedented period of expansion, marked by…
Read More
Clinical Laboratories Fortify Against Inevitable Disruptions, Prioritizing Sample Integrity and Sustained Operations Through Expert-Driven Strategies.
Clinical laboratories, the bedrock of modern healthcare diagnostics, face an increasingly complex array of potential disruptions that threaten their critical…
Read MoreYOU MAY HAVE MISSED
